Theriva Biologics, Inc.TOVXNYSE
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank50
3Y CAGR-22.5%
5Y CAGR-10.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-22.5%/yr
vs +5.4%/yr prior
5Y CAGR
-10.4%/yr
Recent deceleration
Acceleration
-27.8pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 33.20% |
| 2023 | 12.77% |
| 2022 | -1618.95% |
| 2021 | 71.21% |
| 2020 | 27.79% |
| 2019 | 57.39% |
| 2018 | 49.77% |
| 2017 | 57.79% |
| 2016 | 46.66% |
| 2015 | -69.69% |